The results of this meta-analysis indicate that quercetin has the ability to lower BP without causing any significant adverse effects and may have the ability to significantly reduce TGs. Moreover, quercetin consumption significantly increased HDL-C levels in cohorts that consumed quercetin for longer periods (≥ 8 weeks) and in trials with a parallel design. Quercetin consumption may be an effective dietary modality to reduce CVD risk in humans.
